Diabetes mellitus Samples
Central BioHub offers human serum samples from patients with Diabetes mellitus like Type 2 diabetes mellitus or Unspecified diabetes mellitus. You can use the filter functions to specify your desired products by laboratory parameters and donor specifications like ethnicity, BMI, medication, age and gender. Procurement takes place from consented donors under strict ethical standards. For normal control groups please switch to the category Healthy Donors. If you do not find the research samples you are looking for, please contact us.
641 Products
Human Sodium heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Euthyrox
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 74.5 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Sodium heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Thyrotoxicosis with diffuse goitre [E05.0]
- E11.90
- hypertension
- hypoparathyroidism - partial (not specified)
Medication:
- Euthyrox (Dosages: 112µg)
- Lantus (active agent: insulin glargin)
- Metoprolol
- Novorapid (active agent: insulin aspart)
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 16.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 24.27 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.73 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 18.40 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH147121
1 mL ($43.13)
Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Euthyrox
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 74.5 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Thyrotoxicosis with diffuse goitre [E05.0]
- E11.90
- hypertension
- hypoparathyroidism - partial (not specified)
Medication:
- Euthyrox (Dosages: 112µg)
- Lantus (active agent: insulin glargin)
- Metoprolol
- Novorapid (active agent: insulin aspart)
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 16.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 24.27 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.73 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 18.40 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH147118
1 mL ($43.13)
Human K3EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Euthyrox
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 74.5 kg
- Height:
- 168 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Thyrotoxicosis with diffuse goitre [E05.0]
- E11.90
- hypertension
- hypoparathyroidism - partial (not specified)
Medication:
- Euthyrox (Dosages: 112µg)
- Lantus (active agent: insulin glargin)
- Metoprolol
- Novorapid (active agent: insulin aspart)
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 16.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 24.27 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.73 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 18.40 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH147115
1 mL ($43.13)
Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Euthyrox
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 74.5 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Thyrotoxicosis with diffuse goitre [E05.0]
- E11.90
- hypertension
- hypoparathyroidism - partial (not specified)
Medication:
- Euthyrox (Dosages: 112µg)
- Lantus (active agent: insulin glargin)
- Metoprolol
- Novorapid (active agent: insulin aspart)
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 16.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 24.27 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.73 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 18.40 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH147114
1 mL ($43.13)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 63 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- insulin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 63 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 56 kg/m²
- Weight:
- 152 kg
- Height:
- 165 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (not specified)
- hypertension
- sleep apnoea
Medication:
- insulin
- metformin
Therapy:
- cardiac valve replacement
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH146089
1 mL ($43.13)
Human Serum - Anti-Thyroid peroxidase (aTPO / MAK),... - E05.0
- Donor:
- Gender: Male Age: 43
- Diagnosed disease:
- E10.01 - Type 1 diabetes mellitus with ketoacidosis
- Medication:
- Kreon
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Male
- Age:
- 43 Years
- BMI:
- 36 kg/m²
- Weight:
- 121 kg
- Height:
- 183 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- Type 1 diabetes mellitus with ketoacidosis [E10.01]
Medication:
- Kreon
- Lantus
- Novorapid
- amlodipine
- atorvastatin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 77.00 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 0.80 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.57 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 13.60 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 4.00 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH178719
1 mL ($43.13)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Male Age: 68 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- DPP-4 inhibitor
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 68 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 30 kg/m²
- Weight:
- 98 kg
- Height:
- 180 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (not specified)
- thyroid disease
Medication:
- DPP-4 inhibitor
- blood thinner (because of stroke)
- metformin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 3.10 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH170468
1 mL ($43.13)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 83 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- ASS
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 83 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 30 kg/m²
- Weight:
- 75 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (not specified)
Medication:
- ASS
- Metoprolol
- Ramipril
- amlodipine
- no incretin mimetics
- no insulin
- none
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH169795
1 mL ($43.13)
Human Serum - Anti-Thyroglobulin (aTg / TAK), Anti-... - E06.3
- Donor:
- Gender: Male Age: 18 Ethnic group: European/Caucasian
- Diagnosed disease:
- E10.90
- Medication:
- Levemir
- Parameter:
- Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Male
- Age:
- 18 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 83.5 kg
- Height:
- 173 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Autoimmune thyroiditis [E06.3]
- E10.90
- vitamin D deficiency
Medication:
- Levemir
- Vigantoletten (specific information from donor: Vigantolette 500 IU)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroglobulin (aTg / TAK) |
Qual:
Quant: 230.90 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 149.60 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 2.98 mIU/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 9.80 pmol/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 6.85 pmol/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH167019
1 mL ($43.13)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Female Age: 54 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (reliable diagnosis)
- Medication:
- DuoTrav
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 54 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 29 kg/m²
- Weight:
- 89 kg
- Height:
- 174 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
- glaucoma
- hypothyroidism
Medication:
- DuoTrav (Dosages: 1drop/day)
- Janumet
- L-thyroxine (Dosages: 125/day)
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.50 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH142240
1 mL ($43.13)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.2
- Donor:
- Gender: Female Age: 67 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.2 - Type 2 diabetes mellitus with renal complications - type 2 (not specified)
- Medication:
- L-thyroxine
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 67 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 29 kg/m²
- Weight:
- 89 kg
- Height:
- 174 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hashimotos thyroiditis
- diabetes mellitus [E11.2] - type 2 (not specified)
- hypertension
- hyperuricaemia
Medication:
- L-thyroxine (Dosages: 37.5not specified)
- Ramipril (Dosages: 5mg/day)
- allopurinol (Dosages: 100mg/day)
- metformin (Dosages: 1500/day)
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.10 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH143042
1 mL ($43.13)
Human Serum - Blood glucose (postprandial), Glycosy... - E11.9
- Donor:
- Gender: Female Age: 65 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- metformin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 65 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 33 kg/m²
- Weight:
- 85 kg
- Height:
- 161 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- asthma
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- metformin
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Blood glucose (postprandial) |
Qual:
Quant: 132.00 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 5.70 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165494
1 mL ($43.13)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 79 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Bisoprolol
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 79 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 32 kg/m²
- Weight:
- 75 kg
- Height:
- 153 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90]
- gastritis
- hyperlipoproteinaemia
- hypertension
Medication:
- Bisoprolol
- Ramipril
- Xarelto
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165539
1 mL ($43.13)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Male Age: 64 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- DPP-4 inhibitor
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 64 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 36 kg/m²
- Weight:
- 128 kg
- Height:
- 188 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- coronary heart disease
- diabetes mellitus [E11.90] - type 2 (not specified)
- hypertension
Medication:
- DPP-4 inhibitor
- metformin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.20 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165470
1 mL ($43.13)
Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9
- Donor:
- Gender: Female Age: 74 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- incretin mimetics
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 74 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 29 kg/m²
- Weight:
- 68.8 kg
- Height:
- 155 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
- hypothyroidism
Medication:
- incretin mimetics
- metformin
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Blood sugar (fasting) |
Qual:
Quant: 78.00 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.30 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165492
1 mL ($43.13)
Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- L-thyroxine
- Parameter:
- Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 41 kg/m²
- Weight:
- 112 kg
- Height:
- 165 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
- thyroid disease
Medication:
- L-thyroxine
- Toujeo (specific information from donor: Toujeo 300 U/ml)
- atorvastatin
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Blood sugar (fasting) |
Qual:
Quant: 135.00 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.60 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165497
1 mL ($43.13)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9
- Donor:
- Gender: Female Age: 50 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Metex
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 50 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 31 kg/m²
- Weight:
- 90 kg
- Height:
- 170 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
- rheumatism - 01 (not specified)
- thyroid disease - 01 (not specified)
Medication:
- Metex
- Novorapid
- Protaphan
- insulin
- metformin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.30 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165636
1 mL ($43.13)
Human Serum - Blood glucose (postprandial), Glycosy... - E78.2
- Donor:
- Gender: Female Age: 41 Ethnic group: Not specified
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Prednisolon
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 41 Years
- Ethnic group:
- Not specified
- BMI:
- 32 kg/m²
- Weight:
- 84 kg
- Height:
- 162 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Mixed hyperlipidaemia [E78.2]
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- Prednisolon (specific information from donor: Prednisolon 5 mg)
- insulin
- metformin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose (postprandial) |
Qual:
Quant: 173 mg/dl
Source: this donation
|
|
Method: not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.10 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.30 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165459
1 mL ($43.13)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Female Age: 72 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Candesartan
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 72 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 30 kg/m²
- Weight:
- 84 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90]
- hypertension
- polyarthritis
Medication:
- Candesartan
- amlodipine
- metfomin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.7 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165508
1 mL ($43.13)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 72 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Nebivolol
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 72 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 32 kg/m²
- Weight:
- 80 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90]
- hyperlipoproteinaemia
- hypertension
Medication:
- Nebivolol
- amlodipine
- metfomin
- no incretin mimetics
- no insulin
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165537
1 mL ($43.13)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- L-thyroxine
- Parameter:
- Hepatitis B Virus surface Antigen (HBsAg) Hepatitis C Virus ribonucleic acid (HCV-RNA) Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 18 kg/m²
- Weight:
- 52 kg
- Height:
- 160 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- E11.90
- atrial fibrillation
Medication:
- L-thyroxine (specific information from donor: L-thyroxine 100)
- metformin
- no insulin
Therapy:
- surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis C Virus ribonucleic acid (HCV-RNA) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: qPCR (Real-Time Quantitative PCR) System: Cobas Ampliprep/Cobas TaqMan Roche |
| Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: PCR (Polymerase Chain Reaction) System: Cobas Ampliprep/Cobas TaqMan Roche |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165346
1 mL ($86.25)
Human Serum - Anti-Glutamate Decarboxylase (GAD), A... - E10.90
- Donor:
- Gender: Male Age: 28 Ethnic group: European/Caucasian
- Diagnosed disease:
- E10.90 - type 1 (reliable diagnosis)
- Medication:
- Humalog
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Anti-Zinc transporter 8 Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 28 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 89 kg
- Height:
- 186 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E10.90] - type 1 (reliable diagnosis)
Medication:
- Humalog (specific information from donor: Humalog 20 IU/d)
- Levemir (specific information from donor: Levemir 12 IU/d)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual:
Quant: < 0.70 U/mL
Source: this donation
|
< 1.00 U/mL
Remarks: reference range has changed (before: < 0,90) |
Method: RIA (Radioimmunoassay) System: LKB 147 Gamma Counter Berthold Technologies |
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Zinc transporter 8 |
Qual:
Quant: 85.90 U/mL
Source: this donation
|
< 15.00 U/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH170868
1 mL ($43.13)
Human Serum - Blood glucose (postprandial), Glycosy... - E11.9
- Donor:
- Gender: Female Age: 73 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Lantus
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 73 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 38 kg/m²
- Weight:
- 71.5 kg
- Height:
- 138 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- Lantus
- Liprolog
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose (postprandial) |
Qual:
Quant: 149.00 mg/dl
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.20 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH170850
1 mL ($43.13)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Male Age: 69 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (reliable diagnosis)
- Medication:
- metformin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 69 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 83 kg
- Height:
- 172 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
- metformin
- no incretin mimetics
- no insulin
Therapy:
- implant
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.20 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH166126
1 mL ($43.13)
Human Serum - E11.21
- Donor:
- Gender: Female Age: 76 Ethnic group: Not specified
- Diagnosed disease:
- E11.21
- Medication:
- Januvia
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 76 Years
- Ethnic group:
- Not specified
- BMI:
- 27 kg/m²
- Weight:
- 68 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.21]
Medication:
- Januvia (specific information from donor: Januvia 50 mg)
- Losartan (specific information from donor: Losartan 100 mg)
- Prednisolon (specific information from donor: Prednisolon 1 mg)
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165523
1 mL ($43.13)
Human Serum - Blood glucose (postprandial), Glycosy... - E11.9
- Donor:
- Gender: Female Age: 60 Ethnic group: Not specified
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- metformin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 60 Years
- Ethnic group:
- Not specified
- BMI:
- 30 kg/m²
- Weight:
- 79 kg
- Height:
- 162 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- metformin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose (postprandial) |
Qual:
Quant: 107.00 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.30 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165575
1 mL ($43.13)
Human Serum - E11.9
- Donor:
- Gender: Male Age: 80 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Actrapid
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 80 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 98 kg
- Height:
- 187 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- Actrapid
- Toujeo
- insulin
- metformin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165634
1 mL ($43.13)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9
- Donor:
- Gender: Male Age: 49 Ethnic group: Asian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- L-thyroxine
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 49 Years
- Ethnic group:
- Asian
- BMI:
- 26 kg/m²
- Weight:
- 99 kg
- Height:
- 196 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- L-thyroxine
- Victoza
- insulin
- metformin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.20 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165485
1 mL ($43.13)
Human Serum - Blood glucose (postprandial), Glycosy... - E11.9
- Donor:
- Gender: Male Age: 55 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- insulin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 55 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 34 kg/m²
- Weight:
- 105 kg
- Height:
- 175 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- insulin
- metformin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose (postprandial) |
Qual:
Quant: 250.00 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: > 14 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165579
1 mL ($43.13)
Human Serum - Blood glucose, Glycosylated hemoglobi... - E11.9
- Donor:
- Gender: Male Age: 73 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Lantus
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 73 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 24 kg/m²
- Weight:
- 71 kg
- Height:
- 172 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Stored at:
- < -18 degrees Celsius
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- Lantus
- atorvastatin (specific information from donor: atorvastatin 20)
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose |
Qual:
Quant: < 6.5 %
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.10 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165577
1 mL ($43.13)
